Skip to content

Doximity DOCS Deferred revenue, net of current portion

Deferred revenue, net of current portion at other companies

Microsoft logo
MicrosoftMSFT
Charles River Laboratories logo
Charles River LaboratoriesCRL
Genpact logo
GenpactG

Other financials

Income statement

See full
Revenue$145.4M+5.1%
Gross profit$126.0M+1.7%
Operating income$24.8M-49.0%
Net income$19.1M-69.4%
EPS (diluted)$0.10-67.7%

Balance sheet

See full
Cash & equivalents$219.2M+4.6%
Total debt$10.2M-17.8%
Total equity$950.8M-12.2%
Total assets$1.1B-11.1%

Cash flow

See full
Operating cash flow$109.5M+11.2%
CapEx-
Free cash flow$81.6M-17.1%

Valuation

See full
Market cap$3.75B-60.5%

Profitability

See full
Gross margin89.1%-1.1pp
Operating margin33.3%-6.6pp
Net margin30.4%-8.7pp
FCF margin50.6%+2.7pp

Returns & leverage

See full
Return on equity19.3%-3.2pp
Debt / equity0.0×
Current ratio6.1×-0.9×

Where this comes from

Reported directly by Doximity in its filing.

Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityNoncurrent.

The official record: Doximity’s 10-K, filed May 19, 2026, on SEC EDGAR. View the filing →

Ask your AI about Doximity's deferred revenue, net of current portion.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Doximity's deferred revenue, net of current portion?
Doximity (DOCS) reported deferred revenue, net of current portion of $400K in Q1 2026.
How has Doximity's deferred revenue, net of current portion changed year-over-year?
Doximity's deferred revenue, net of current portion increased by 42.9% year-over-year, from $280K to $400K.
What is the long-term trend for Doximity's deferred revenue, net of current portion?
Over 5 years (2021 to 2026), Doximity's deferred revenue, net of current portion has grown at a 12.7% compound annual growth rate (CAGR), from $220K to $400K.